Murivenna Taila in the Management of Post-Fracture and Post-PoP (Plaster of Paris) Pain and Stiffness: A Retrospective Observational Study with Clinical Evidence Review

Authors

  • Champak Medhi Associate Professor, Dept. of Shalya Tantra, Govt. Ayurvedic College, Guwahati, Assam, India.
  • Jakaria Ahmed Assistant Professor, Department of Shalya Tantra, IA Ayurvedic Medical College, Ri-Bhoi, Meghalaya, India.

DOI:

https://doi.org/10.47070/ayushdhara.v13i3.2755

Keywords:

Murivenna Taila, Post-fracture pain, POP cast removal, Ayurvedic external therapy, Bhagna Chikitsa, Abhyanga, Musculoskeletal rehabilitation, Ayurveda

Abstract

Murivenna Taila, a classical Ayurvedic medicated oil with established anti-inflammatory, analgesic, and tissue-regenerative properties, is widely used in Kerala and is referenced in Kerala-specific Ayurvedic texts for fracture management (Bhagna Chikitsa). Objective: To evaluate the clinical effectiveness of Murivenna Taila applied externally in reducing pain, edema, and joint stiffness in patients with post-fracture sequelae and post-POP cast removal syndrome, through retrospective observational analysis of OPD case records. Methods: Retrospective analysis of 30 OPD case records over a 16-month period (December 2024 to March 2026) was conducted. Patients who had received external application of Murivenna Taila as part of integrative Ayurvedic management for post-fracture pain or post-POP stiffness were included. Subjective parameters (Pain-VAS, joint stiffness, and Patient Global Impression of Change) and objective parameters (swelling/edema grade and restricted range of motion grade) were graded and assessed at baseline, day 7, and day 14. Results: Total number of patients 30 (mean age 37.4±11.2 years; M:F = 19:11). 27 (90%) reported clinically meaningful pain reduction (VAS reduction ≥2 points) within 14 days of initiating Murivenna Taila application. Mean VAS at baseline was 7.13±1.33, reducing to 2.63±0.78 at day 14 (paired t=21.4, p<0.001). Reduction in NJSS scores from baseline was observed in 29 out of 30 patients (96.7%) by day 14 (paired t=17.8, p<0.001). Grade-wise reduction was also observed for swelling/edema and restricted range of motion. Nevertheless, 2 patients reported no subjective overall improvement on PGIC assessment. Conclusion: External application of Murivenna Taila demonstrates promising analgesic and anti-stiffness effects in post-fracture and post-POP conditions. It offers a safe, accessible, and cost-effective adjunct to conventional rehabilitation. Prospective controlled studies are warranted.

Downloads

Download data is not yet available.

Author Biography

  • Champak Medhi, Associate Professor, Dept. of Shalya Tantra, Govt. Ayurvedic College, Guwahati, Assam, India.

    Associate Professor at the Government Ayurvedic College, Guwahati, Assam,

Published

08-07-2026

Issue

Section

Articles

How to Cite

1.
Murivenna Taila in the Management of Post-Fracture and Post-PoP (Plaster of Paris) Pain and Stiffness: A Retrospective Observational Study with Clinical Evidence Review. Ayushdhara [Internet]. 2026 Jul. 8 [cited 2026 Aug. 21];13(3):81-9. Available from: https://ayushdhara.in/index.php/ayushdhara/article/view/2755